Received Oct 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | OT |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
sweating; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): MOD-2025-789451 (moderna). A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), in Jul2025 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (SPIKEVAX), as 1 df, single intramuscular for covid-19 prophylaxis. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna covid vaccine (last dose), administration date: 2023, for COVID-19 immunisation, reaction(s): "Sweating". The following information was reported: HYPERHIDROSIS (non-serious), outcome "unknown", described as "sweating". Additional information: The patient always had excessive problems, like getting the vaccine. The last dose of the Moderna COVID vaccine was received probably in 2023. Sweating occurred after the vaccine. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.